Section 16 Filings :: NeoGenomics, Inc. (NEO)

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring

Menu

Test Search

Filing Type

Year

SEC Filings
Date	Form	Description	XBRL	Pages